Skip to main content

Table 2 The therapeutic response in CHB patients after treatment.

From: Correlation between the suppressor of cytokine signaling-1 and 3 and hepatitis B virus: possible roles in the resistance to interferon treatment

Treatment course Responders (N = 8) Non-responders (N = 16)
HBeAg seroconversion Non-HBeAg seroconversion HBeAg seroconversion Non-HBeAg seroconversion
24 weeks 3 2 0 9
48 weeks 3 0 0 7